NCT06821191View on ClinicalTrials.gov

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

January 7, 2027

Conditions
Coronary Artery Disease
Interventions
DRUG

clopidogrel 75 mg

Clopidogrel 75 mg od for 30 ± 5 days

DRUG

Prasugrel 5 mg

Prasugrel 5 mg od for 30 ± 5 days

Trial Locations (1)

32209

RECRUITING

University of Florida, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER